2020
DOI: 10.21203/rs.3.rs-39378/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Ameliorating Ribosylation-induced Aβ Pathology by Berberine via Inhibiting mTOR/p70S6K Signaling

Abstract: Abstract Background: Berberine (BBR) plays a neuroprotective role in the pathogenesis of Alzheimer’s disease (AD), inhibiting β-amyloid (Aβ) production and promoting Aβ clearance. Advanced glycation end products (AGEs) promote Aβ aggregation and tau hyperphosphorylation. The activation of mTOR signaling occurring at the early stage of AD has a prominent impact on the Aβ production. This work focused on whether BBR regulates the production and clea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 41 publications
(41 reference statements)
0
1
0
Order By: Relevance
“…However, BBR intervention can alleviate cognitive decline in AD mice by inhibiting Aβ production, Tau hyperphosphorylation and autophagy clearance [28,29]. Our previous study found that BBR ameliorates ribosylation induced Aβ pathology by inhibiting mTOR/p70S6K signaling and promoting autophagy, thereby improving spatial learning and memory in APP/PS1 mice [30].…”
Section: Introductionmentioning
confidence: 99%
“…However, BBR intervention can alleviate cognitive decline in AD mice by inhibiting Aβ production, Tau hyperphosphorylation and autophagy clearance [28,29]. Our previous study found that BBR ameliorates ribosylation induced Aβ pathology by inhibiting mTOR/p70S6K signaling and promoting autophagy, thereby improving spatial learning and memory in APP/PS1 mice [30].…”
Section: Introductionmentioning
confidence: 99%